Medicare Enrolled

Dr. Fernando Melaragno, DO

Endocrinology · Erie, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
5535 PEACH ST, Erie, PA 16509
8148683488
In practice since 2008 (18 years)
NPI: 1912161613 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Melaragno from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melaragno? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Melaragno

Dr. Fernando Melaragno is an endocrinology specialist in Erie, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Melaragno performed 382 Medicare services across 251 unique beneficiaries.

Between the years covered by Open Payments, Dr. Melaragno received a total of $16,730 from 67 pharmaceutical and/or device companies across 991 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Melaragno is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ 382 Medicare services $16,730 industry payments

Medicare Practice Summary

Medicare Utilization ↗
382
Medicare services
Bottom 40% in PA for endocrinology
251
Unique beneficiaries
$53
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~21 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
205 $67 $293
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
69 $9 $39
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
50 $26 $93
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
39 $94 $404
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
19 $51 $202
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$16,730
Total received (2018-2024)
Avg $2,390/year across 7 years
Top 17% in PA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
991
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,730 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,885
2023
$2,477
2022
$2,807
2021
$1,700
2020
$642
2019
$2,572
2018
$3,648

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$458
Lilly USA, LLC
$437
Madrigal Pharmaceuticals
$299
AstraZeneca Pharmaceuticals LP
$257
Amgen Inc.
$193
Abbott Laboratories
$171
Bayer Healthcare Pharmaceuticals Inc.
$143
Medtronic, Inc.
$124
Novartis Pharmaceuticals Corporation
$97
Xeris Pharmaceuticals, Inc.
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
Neurocrine Biosciences, Inc.
$80
CeQur Corporation
$62
Amneal Pharmaceuticals LLC
$53
Antares Pharma, Inc.
$53
PFIZER INC.
$41
SANOFI-AVENTIS U.S. LLC
$38
Alexion Pharmaceuticals, Inc.
$38
Ultragenyx Pharmaceutical Inc.
$26
Kyowa Kirin, Inc.
$26
Corcept Therapeutics
$21
Collegium Pharmaceutical, Inc.
$20
Insulet Corporation
$18
Chiesi USA, Inc.
$17
Teva Pharmaceuticals USA, Inc.
$16
Ascensia Diabetes Care Us Inc.
$15
BETA BIONICS, INC.
$6
Top 3 companies account for 41.4% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$3,015
AstraZeneca Pharmaceuticals LP
$1,630
Lilly USA, LLC
$1,502
Boehringer Ingelheim Pharmaceuticals, Inc.
$887
SANOFI-AVENTIS U.S. LLC
$783
Amgen Inc.
$753
Medtronic MiniMed, Inc.
$671
Merck Sharp & Dohme Corporation
$595
Abbott Laboratories
$575
Amarin Pharma Inc.
$575
Janssen Pharmaceuticals, Inc
$535
Amneal Pharmaceuticals LLC
$351
Madrigal Pharmaceuticals
$299
Bayer Healthcare Pharmaceuticals Inc.
$293
AbbVie, Inc.
$291
Corcept Therapeutics
$280
Merck Sharp & Dohme LLC
$265
Medtronic, Inc.
$226
Neurocrine Biosciences, Inc.
$211
Xeris Pharmaceuticals, Inc.
$197
Novartis Pharmaceuticals Corporation
$189
CeQur Corporation
$158
Gemini Laboratories, LLC
$153
Insulet Corporation
$151
Antares Pharma, Inc.
$141
Biohaven Pharmaceutical Holding Company Ltd.
$121
Tandem Diabetes Care, Inc.
$120
Horizon Therapeutics plc
$119
Valeritas, Inc.
$99
ABBVIE INC.
$98
ARBOR PHARMACEUTICALS, INC.
$92
Radius Health, Inc.
$91
Biohaven Pharmaceuticals, Inc.
$89
Regeneron Healthcare Solutions, Inc.
$78
PFIZER INC.
$77
Neurelis, Inc.
$76
Teva Pharmaceuticals USA, Inc.
$72
Bayer HealthCare Pharmaceuticals Inc.
$66
LifeScan, Inc.
$60
AbbVie Inc.
$49
Alexion Pharmaceuticals, Inc.
$49
Endo Pharmaceuticals Inc.
$48
Dexcom, Inc.
$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$42
E.R. Squibb & Sons, L.L.C.
$39
Boston Scientific Corporation
$37
MannKind Corporation
$33
UCB, Inc.
$32
Alfasigma USA, Inc.
$28
Ultragenyx Pharmaceutical Inc.
$26
Supernus Pharmaceuticals, Inc.
$26
Lundbeck LLC
$26
Kyowa Kirin, Inc.
$26
Ascendis Pharma Inc
$26
RECORDATI_RARE_DISEASES_INC.
$22
EUSA Pharma (US) LLC
$22
GlaxoSmithKline, LLC.
$21
Collegium Pharmaceutical, Inc.
$20
Chiesi USA, Inc.
$17
IBSA Pharma Inc.
$16
Harmony Biosciences LLC
$16
DEXCOM, INC.
$16
Ferring Pharmaceuticals Inc.
$15
SANOFI PASTEUR INC.
$15
Ascensia Diabetes Care Us Inc.
$15
Apria Healthcare LLC
$12
BETA BIONICS, INC.
$6
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AJOVY · AREXVY · AUSTEDO · Aimovig · Androgel · Austedo XR · BAQSIMI · BASAGLAR · BELSOMRA · Briviact · CeQur Simplicity · Confirm Rx · Creon · Crysvita · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FLUZONE HIGH-DOSE · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · Gliadel · HUMULIN · INGREZZA · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKAMET · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · Kerendia · Korlym · LANTUS · LEQVIO · LOKELMA · Lupron · Lupron Depot · MOUNJARO · MYCAPSSA · Medela · Minimed 670G System · NASCOBAL · NOCDURNA · NURTEC ODT · Norditropin · Omnipod · OneTouch · Ongentys · Otezla · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QULIPTA · RECORLEV · RESMETIROM · REXULTI · REZDIFFRA · RYBELSUS · Repatha · Rybelsus · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · SPECTRA WAVEWRITER · STEGLATRO · STEGLUJAN · STRENSIQ · SUPPRELIN LA · SYNJARDY · SYNTHROID · Saxenda · Strensiq · Sylvant · Synthroid · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Triptodur · Tymlos · UBRELVY · ULTOMIRIS · UNITHROID · V-GO · VALTOCO · Vascepa · Victoza · Wakix · Wegovy · XARELTO · XIFAXAN · XTAMPZA · XYOSTED · ZEPBOUND · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Erie?
Compare endocrinologists in the Erie area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
7
Per 100K population
2.6
County median income
$61,476
Nearest hospital
LECOM MEDICAL CENTER AND BEHAVIORAL HEALTH PAV
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Melaragno is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of PA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Melaragno experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Melaragno performed 205 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Melaragno receive payments from pharmaceutical companies?
Yes. Dr. Melaragno received a total of $16,730 from 67 companies across 991 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melaragno's costs compare to other endocrinologists in Erie?
Dr. Melaragno's average Medicare payment per service is $53. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melaragno) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →